Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000102909-25-000030·10x Genomics, Inc.
Schedule 13G ownership disclosure
10X Genomics Inc
Common Stock · CUSIP: 88025U109
Event date: 2025-09-30
- Filing-level shares
- 13,274,332
- Percent of class
- 11.60%
- The Vanguard Group
Shares: 13,274,332 · Class: 11.60%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-25-000030
- Form type
- SCHEDULE 13G/A
- Filer
- 10x Genomics, Inc.
- CIK
- CIK 1770787
- Filed
- Oct 30, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership